Navigation Links
Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology
Date:10/17/2008

his father, Porky Sullivan, so he could play baseball with the neighborhood boys without the benefit of seeing the ball. It became the most popular game on the block. And "Sullivan's Rules" became the rules to play by in the sighted world and that meant playing almost anything.

One of Sullivan's first rules is that "Any negative can be turned into positive." Born prematurely in 1947, Tom was given too much oxygen while in an incubator. Though it saved his life, it cost him his eyesight. The "inconvenience" of being blind has never kept Tom Sullivan from competing in a world where he realized that to be equal, for him, meant that he must be better. Even as he may have had to change the rules slightly, he has proven that one need not be limited by a handicap whether it is playing backyard baseball as a youngster, or in any activity he's pursued. He's an avid snow skier and a marathon runner, and has recently been inducted into the National Wrestling Hall of Fame in Stillwater, Oklahoma.

In his latest title Adventures in Darkness, Tom takes readers through his monumental eleventh summer. Blind since birth, Tom lived in a challenging world of isolation and special treatment. But he was driven to break out and live as sighted people do. This book is a hair-raising, heart-warming experience that culminates in Tom's determination to realize his dreams of a "normal" life.

About the Juvenile Diabetes Research Foundation

JDRF is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.16 billion to diabetes research, including more than $137 million in FY2007. In FY2007, the Foundation funded 700 centers, grants and fellowships in 20 countries.

About the Oklahoma Academy of Ophthalmology


'/>"/>

SOURCE Oklahoma Academy of Ophthalmology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
2. Medical Services International Maintains Pace in Second Quarter
3. CEOs Need an Advertising Check Up or Second Opinion
4. Trojan(R) Ranks U.S. Colleges and Universities in Second Annual Sexual Health Report Card
5. HealthMedia Revolution Explodes in Second Quarter
6. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
7. Acting Surgeon General Announces National Initiatives to Protect Children by Reducing Exposure to Secondhand Smoke
8. Roller Derby Author Cheats Death a Second Time
9. Launch of second European Cancer Research Funding survey
10. Secondhand smoke increases teen test failure
11. Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Global measles deaths drop wor... (Vocus) December 1, 2009 -- WHAT: Measles In... Centers for Disease Control and Prevention, the U...alth Organization – will announce the latest...erence on Thursday, December 3, 2009 at 10:00 a.m....
(Date:12/1/2009)... , Gay Men,s Health Crisis Encourages Peopl...Dec. 1 Today on World A...ming its commitment to continue helping diverse gr...including people struggling with crystal methamphe...eractive crystal methamphetamine resource, www.My...
(Date:12/1/2009)...ion exposures in younger women may up chances of d...(HealthDay News) -- Mammograms may actually boost ... a new study suggests. , Dutch researchers anal...ing the effect of low-dose radiation exposure from... boosting breast cancer risk and two looking at th...
(Date:12/1/2009)... Pilots will enable local organ...e of safe water for consumers who lack access , ..., 2009 -- Acumen Fund, a nonprofit venture firm ad...nounced that it has selected four organizations in... of safe water transportation and storage. , , ,Th...
(Date:12/1/2009)... , IRVINE, Calif., Dec. 1 /PRNewswire...ntor of Pulse CO-Oximetry(TM) and Measure-Through ...ounced FDA clearance of its latest innovation -- M...viding noninvasive and continuous respiration rate...nces patient compliance. Masimo Rainbow SET Acous...
Breaking Medicine News(10 mins):Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 2Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 3Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 3Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6
...ase 3 Program Expected to Begin in December - , ...maceuticals, a division of Wyeth (NYSE: WYE ), t...nical trial of neratinib (HKI-272) in women with a...he ErbB-2 receptor (also known as HER-2 or Neu). ...
...c. 12 The Female Health Company (NYSE Alternext...dministration,s (FDA) Obstetrics and Gynecology De...t the company,s second-generation female condom, t...ndition that the FC2 Female Condom,s instructions ...
...nly approved peginterferon in combination with rib...nic hepatitis C addresses unmet medical need , ...poration (NYSE: SGP ) today announced that the U...tion therapy for use in previously untreated patie...
...Dec. 12 University Hospitals Case Medical Center ... pleased to announce the installment of the Hot No...od vending machine. UH Case Medical Center will h...Hospitals prides itself on the diversity of its pa...
... onto a scale after a calorie-filled holiday seaso...lish. , But in the late 19th century, scales were...swer to Guitar Hero. , "A family would think it f...doctoral Fellow in the Modeling Interdisciplinary ...
...RINGS, Colo., Dec. 12 Most of the 300,000,public ...n December 19, 2008,according to the Consumer Prod... with the Virginia Graeme Baker Pool & Spa Saf...rapped on a drain in a,private in-ground spa. "Ev...
Other Medicine News:Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 2Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 3Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 2Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 3Health News:Once upon a time, scales were displayed in parlors, not hidden in bathrooms 2Health News:Controversial New Pool & Spa Safety Act Will Create Public Pool Closures Nationwide 2Health News:Controversial New Pool & Spa Safety Act Will Create Public Pool Closures Nationwide 3Health News:Controversial New Pool & Spa Safety Act Will Create Public Pool Closures Nationwide 4Health News:Controversial New Pool & Spa Safety Act Will Create Public Pool Closures Nationwide 5
(Date:12/1/2009)...ec. 1 Sleep Solutions®, Inc. ... home testing and evaluation of sleep-disordered b...sett, M.D., as its chief executive officer. Hasse...e, during its growth from a $250 million healthcar...der in total population health, and its subsequent...
(Date:12/1/2009)... At this year,s annual meeting of ...Royal Philips Electronics ( PHG, AEX: PHI) will in...lutions that provides radiologists the ability to ...t to help drive quality and efficiency. Showcasin... highlight new capabilities for its portfolio of d...
(Date:12/1/2009)...Dec. 1 Exagen Diagnostics, Inc., a...develops and markets proprietary genomic tests, to...airman of the company,s board of directors and chi...n, Glenn was managing partner of Windamere Venture...omedical companies including Prometheus Laboratori...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Lutronic 28R 29 Becomes Official Laser for Lifestyle Lift 28R 29 52233 1Lutronic 28R 29 Becomes Official Laser for Lifestyle Lift 28R 29 52233 2Millions in U S Cant Afford Health Insurance 52232 1Millions in U S Cant Afford Health Insurance 52232 2My InnerView and UW Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 52230 1My InnerView and UW Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 52230 2My InnerView and UW Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 52230 3
...cts Very Low Dose Glucagon ahead of Phase 2 Clinic..., SAN FRANCISCO, Jan. 8 DiObex, Inc., a privatel... for metabolic diseases,announced today that it ha...nd Trademark Office for the use of very low dose g...induced hypoglycemia in diabetes patients. The,pat...
...Calif., Jan. 8 Nektar,Therapeutics (Nasdaq: NKTR...al development program to evaluate NKTR-102 (PEG-i... cancer. NKTR-102 is Nektar,s lead,oncolytic candi...,PEGylation technology platform., "The start of t...er is,a major achievement for Nektar," said Howard...
Other Medicine Technology:DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia 2Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer 2Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer 3Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer 4
Loop Electrodes
Elmed Hand Activated Monopolar Forceps
Nova Epi-fluorescence
...first inverted microscope to take full advantage o...n enables optical input/output of light and images...equipment. Extendable "Stratum Structure" configur...urce and other attachments within the infinity pat...
Medicine Products: